GlassScriptPhysician profile
Sunny Kar
NPI 1356754907
$5,548.87
in general payments reported to CMS, 2019-2025
10 companies · $4,070 in 2025
The $4,070 reported for 2025 was more than what 86% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $289 · 2023: $885 · 2024: $108 · 2025: $4,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,847 · Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,847.35 |
| Food and Beverage | $716.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,477.27 | 2021-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $534.49 | 2023 | Advantagerib |
| Davol INC. | $156.62 | 2023 | Phasix Mesh |
| Stryker Corporation | $135.82 | 2022 | |
| Haemonetics Corporation | $88.21 | 2024 | Teg6s Hemostasis System |
| Kerecis Limited | $51.61 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Avita Medical Americas, LLC | $44.83 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Becton, Dickinson and Company | $21.52 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.79 | 2024 | Andexxa |
| Teleflex LLC | $18.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunny Kar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.